Correlation Between Estrella Immunopharma and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Estrella Immunopharma and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Estrella Immunopharma and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and NLS Pharmaceutics.

Diversification Opportunities for Estrella Immunopharma and NLS Pharmaceutics

0.08

Correlation Coefficient

Estrella Immunopharma  NLS Pharmaceutics

Significant diversification

The 3 months correlation between Estrella and NLS is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and NLS Pharmaceutics

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 1.99 times more return on investment than NLS Pharmaceutics. However, Estrella Immunopharma is 1.99 times more volatile than NLS Pharmaceutics AG. It trades about 0.13 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.04 per unit of risk. If you would invest  9.10  in Estrella Immunopharma on November 28, 2024 and sell it today you would earn a total of  1.90  from holding Estrella Immunopharma or generate 20.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	44.07%
Values	Daily Returns

Estrella Immunopharma  vs.  NLS Pharmaceutics AG

Estrella Immunopharma

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Estrella Immunopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

NLS Pharmaceutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days NLS Pharmaceutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Estrella Immunopharma and NLS Pharmaceutics

The main advantage of trading using opposite Estrella Immunopharma and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind Estrella Immunopharma and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.